Dr Kadia Mary Bundu, MD | |
14760 Main Street, Suite 301, Upper Marlboro, MD 20772 | |
(301) 952-1370 | |
(301) 952-1372 |
Full Name | Dr Kadia Mary Bundu |
---|---|
Gender | Female |
Speciality | Anesthesiology |
Location | 14760 Main Street, Upper Marlboro, Maryland |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1467752394 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207L00000X | Anesthesiology | D77887 (Maryland) | Primary |
Entity Name | Kaiser Foundation Health Plan Of The Mid-atlantic States,inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1952461816 PECOS PAC ID: 3779495858 Enrollment ID: O20040105000308 |
News Archive
A George Mason University researcher team has revealed the specific process by which the HIV virus infects healthy T cells-a process previously unknown. The principal investigator, HIV researcher Yuntao Wu, says he hopes this breakthrough will start a new line on inquiry into how researchers can use this knowledge to create drugs that could limit or halt HIV infection.
3SBio Inc.("3SBio" or "Company"), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced that the annual general meeting of shareholders of 3SBio Inc. will be held on October 12, 2009 at 10:00 a.m., Shenyang time, at No.3 A1, Road 10, Shenyang Economy & Technology Development Zone, Shenyang 110027, People's Republic of China. The shareholder record date is September 12, 2009.
A major social science study to accompany the Government's Bovine TB Badger Vaccine Deployment Project, to be launched this summer [2010], will be led by a researcher from the University of the West of England, with colleagues from the Countryside and Community Research Institute, in collaboration with Exeter and Cardiff Universities, Drew Associates Limited, the Veterinary Laboratories Agency and the Food and Environment Research Agency.
People with more copies of a gene that helps to fight HIV are less likely to become infected with the virus or to develop AIDS than those of the same geographical ancestry, such as European Americans, who have fewer copies of the gene, according to a study funded by the National Institute of Allergy and Infectious Diseases (NIAID).
Today, the International Rett Syndrome Foundation announced that it will provide $200,000 in 2009 to support a newly proposed clinical trial with a growth-factor based treatment for Rett Syndrome. The study will be carried out by a team of clinical trials specialists at the Boston Children's Hospital, led by Dr. Omar Khwaja MD, PhD and will be the first potentially disease modifying therapy ever to be tested in Rett syndrome patients.
› Verified 8 days ago
Entity Name | Kaiser Foundation Health Plan Of The Mid-atlantic States,inc |
---|---|
Entity Type | Part B Supplier - Ambulatory Surgical Center |
Entity Identifiers | NPI Number: 1578638425 PECOS PAC ID: 3779495858 Enrollment ID: O20040805001280 |
News Archive
A George Mason University researcher team has revealed the specific process by which the HIV virus infects healthy T cells-a process previously unknown. The principal investigator, HIV researcher Yuntao Wu, says he hopes this breakthrough will start a new line on inquiry into how researchers can use this knowledge to create drugs that could limit or halt HIV infection.
3SBio Inc.("3SBio" or "Company"), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced that the annual general meeting of shareholders of 3SBio Inc. will be held on October 12, 2009 at 10:00 a.m., Shenyang time, at No.3 A1, Road 10, Shenyang Economy & Technology Development Zone, Shenyang 110027, People's Republic of China. The shareholder record date is September 12, 2009.
A major social science study to accompany the Government's Bovine TB Badger Vaccine Deployment Project, to be launched this summer [2010], will be led by a researcher from the University of the West of England, with colleagues from the Countryside and Community Research Institute, in collaboration with Exeter and Cardiff Universities, Drew Associates Limited, the Veterinary Laboratories Agency and the Food and Environment Research Agency.
People with more copies of a gene that helps to fight HIV are less likely to become infected with the virus or to develop AIDS than those of the same geographical ancestry, such as European Americans, who have fewer copies of the gene, according to a study funded by the National Institute of Allergy and Infectious Diseases (NIAID).
Today, the International Rett Syndrome Foundation announced that it will provide $200,000 in 2009 to support a newly proposed clinical trial with a growth-factor based treatment for Rett Syndrome. The study will be carried out by a team of clinical trials specialists at the Boston Children's Hospital, led by Dr. Omar Khwaja MD, PhD and will be the first potentially disease modifying therapy ever to be tested in Rett syndrome patients.
› Verified 8 days ago
Entity Name | Kaiser Foundation Health Plan Of The Mid-atlantic States,inc |
---|---|
Entity Type | Part B Supplier - Ambulatory Surgical Center |
Entity Identifiers | NPI Number: 1073678637 PECOS PAC ID: 3779495858 Enrollment ID: O20100729000796 |
News Archive
A George Mason University researcher team has revealed the specific process by which the HIV virus infects healthy T cells-a process previously unknown. The principal investigator, HIV researcher Yuntao Wu, says he hopes this breakthrough will start a new line on inquiry into how researchers can use this knowledge to create drugs that could limit or halt HIV infection.
3SBio Inc.("3SBio" or "Company"), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced that the annual general meeting of shareholders of 3SBio Inc. will be held on October 12, 2009 at 10:00 a.m., Shenyang time, at No.3 A1, Road 10, Shenyang Economy & Technology Development Zone, Shenyang 110027, People's Republic of China. The shareholder record date is September 12, 2009.
A major social science study to accompany the Government's Bovine TB Badger Vaccine Deployment Project, to be launched this summer [2010], will be led by a researcher from the University of the West of England, with colleagues from the Countryside and Community Research Institute, in collaboration with Exeter and Cardiff Universities, Drew Associates Limited, the Veterinary Laboratories Agency and the Food and Environment Research Agency.
People with more copies of a gene that helps to fight HIV are less likely to become infected with the virus or to develop AIDS than those of the same geographical ancestry, such as European Americans, who have fewer copies of the gene, according to a study funded by the National Institute of Allergy and Infectious Diseases (NIAID).
Today, the International Rett Syndrome Foundation announced that it will provide $200,000 in 2009 to support a newly proposed clinical trial with a growth-factor based treatment for Rett Syndrome. The study will be carried out by a team of clinical trials specialists at the Boston Children's Hospital, led by Dr. Omar Khwaja MD, PhD and will be the first potentially disease modifying therapy ever to be tested in Rett syndrome patients.
› Verified 8 days ago
Entity Name | Kaiser Foundation Health Plan Of The Mid-atlantic States,inc |
---|---|
Entity Type | Part B Supplier - Ambulatory Surgical Center |
Entity Identifiers | NPI Number: 1366781700 PECOS PAC ID: 3779495858 Enrollment ID: O20130507000207 |
News Archive
A George Mason University researcher team has revealed the specific process by which the HIV virus infects healthy T cells-a process previously unknown. The principal investigator, HIV researcher Yuntao Wu, says he hopes this breakthrough will start a new line on inquiry into how researchers can use this knowledge to create drugs that could limit or halt HIV infection.
3SBio Inc.("3SBio" or "Company"), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced that the annual general meeting of shareholders of 3SBio Inc. will be held on October 12, 2009 at 10:00 a.m., Shenyang time, at No.3 A1, Road 10, Shenyang Economy & Technology Development Zone, Shenyang 110027, People's Republic of China. The shareholder record date is September 12, 2009.
A major social science study to accompany the Government's Bovine TB Badger Vaccine Deployment Project, to be launched this summer [2010], will be led by a researcher from the University of the West of England, with colleagues from the Countryside and Community Research Institute, in collaboration with Exeter and Cardiff Universities, Drew Associates Limited, the Veterinary Laboratories Agency and the Food and Environment Research Agency.
People with more copies of a gene that helps to fight HIV are less likely to become infected with the virus or to develop AIDS than those of the same geographical ancestry, such as European Americans, who have fewer copies of the gene, according to a study funded by the National Institute of Allergy and Infectious Diseases (NIAID).
Today, the International Rett Syndrome Foundation announced that it will provide $200,000 in 2009 to support a newly proposed clinical trial with a growth-factor based treatment for Rett Syndrome. The study will be carried out by a team of clinical trials specialists at the Boston Children's Hospital, led by Dr. Omar Khwaja MD, PhD and will be the first potentially disease modifying therapy ever to be tested in Rett syndrome patients.
› Verified 8 days ago
Entity Name | Kaiser Foundation Health Plan Of The Mid-atlantic States,inc |
---|---|
Entity Type | Part B Supplier - Ambulatory Surgical Center |
Entity Identifiers | NPI Number: 1497023188 PECOS PAC ID: 3779495858 Enrollment ID: O20131029000108 |
News Archive
A George Mason University researcher team has revealed the specific process by which the HIV virus infects healthy T cells-a process previously unknown. The principal investigator, HIV researcher Yuntao Wu, says he hopes this breakthrough will start a new line on inquiry into how researchers can use this knowledge to create drugs that could limit or halt HIV infection.
3SBio Inc.("3SBio" or "Company"), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced that the annual general meeting of shareholders of 3SBio Inc. will be held on October 12, 2009 at 10:00 a.m., Shenyang time, at No.3 A1, Road 10, Shenyang Economy & Technology Development Zone, Shenyang 110027, People's Republic of China. The shareholder record date is September 12, 2009.
A major social science study to accompany the Government's Bovine TB Badger Vaccine Deployment Project, to be launched this summer [2010], will be led by a researcher from the University of the West of England, with colleagues from the Countryside and Community Research Institute, in collaboration with Exeter and Cardiff Universities, Drew Associates Limited, the Veterinary Laboratories Agency and the Food and Environment Research Agency.
People with more copies of a gene that helps to fight HIV are less likely to become infected with the virus or to develop AIDS than those of the same geographical ancestry, such as European Americans, who have fewer copies of the gene, according to a study funded by the National Institute of Allergy and Infectious Diseases (NIAID).
Today, the International Rett Syndrome Foundation announced that it will provide $200,000 in 2009 to support a newly proposed clinical trial with a growth-factor based treatment for Rett Syndrome. The study will be carried out by a team of clinical trials specialists at the Boston Children's Hospital, led by Dr. Omar Khwaja MD, PhD and will be the first potentially disease modifying therapy ever to be tested in Rett syndrome patients.
› Verified 8 days ago
Entity Name | Johns Hopkins University |
---|---|
Entity Type | Part B Supplier - Hospital Department(s) |
Entity Identifiers | NPI Number: 1740286418 PECOS PAC ID: 4981745098 Enrollment ID: O20200123000419 |
News Archive
A George Mason University researcher team has revealed the specific process by which the HIV virus infects healthy T cells-a process previously unknown. The principal investigator, HIV researcher Yuntao Wu, says he hopes this breakthrough will start a new line on inquiry into how researchers can use this knowledge to create drugs that could limit or halt HIV infection.
3SBio Inc.("3SBio" or "Company"), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced that the annual general meeting of shareholders of 3SBio Inc. will be held on October 12, 2009 at 10:00 a.m., Shenyang time, at No.3 A1, Road 10, Shenyang Economy & Technology Development Zone, Shenyang 110027, People's Republic of China. The shareholder record date is September 12, 2009.
A major social science study to accompany the Government's Bovine TB Badger Vaccine Deployment Project, to be launched this summer [2010], will be led by a researcher from the University of the West of England, with colleagues from the Countryside and Community Research Institute, in collaboration with Exeter and Cardiff Universities, Drew Associates Limited, the Veterinary Laboratories Agency and the Food and Environment Research Agency.
People with more copies of a gene that helps to fight HIV are less likely to become infected with the virus or to develop AIDS than those of the same geographical ancestry, such as European Americans, who have fewer copies of the gene, according to a study funded by the National Institute of Allergy and Infectious Diseases (NIAID).
Today, the International Rett Syndrome Foundation announced that it will provide $200,000 in 2009 to support a newly proposed clinical trial with a growth-factor based treatment for Rett Syndrome. The study will be carried out by a team of clinical trials specialists at the Boston Children's Hospital, led by Dr. Omar Khwaja MD, PhD and will be the first potentially disease modifying therapy ever to be tested in Rett syndrome patients.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Kadia Mary Bundu, MD 14760 Main Street, Suite 301, Upper Marlboro, MD 20772 Ph: (301) 952-1370 | Dr Kadia Mary Bundu, MD 14760 Main Street, Suite 301, Upper Marlboro, MD 20772 Ph: (301) 952-1370 |
News Archive
A George Mason University researcher team has revealed the specific process by which the HIV virus infects healthy T cells-a process previously unknown. The principal investigator, HIV researcher Yuntao Wu, says he hopes this breakthrough will start a new line on inquiry into how researchers can use this knowledge to create drugs that could limit or halt HIV infection.
3SBio Inc.("3SBio" or "Company"), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced that the annual general meeting of shareholders of 3SBio Inc. will be held on October 12, 2009 at 10:00 a.m., Shenyang time, at No.3 A1, Road 10, Shenyang Economy & Technology Development Zone, Shenyang 110027, People's Republic of China. The shareholder record date is September 12, 2009.
A major social science study to accompany the Government's Bovine TB Badger Vaccine Deployment Project, to be launched this summer [2010], will be led by a researcher from the University of the West of England, with colleagues from the Countryside and Community Research Institute, in collaboration with Exeter and Cardiff Universities, Drew Associates Limited, the Veterinary Laboratories Agency and the Food and Environment Research Agency.
People with more copies of a gene that helps to fight HIV are less likely to become infected with the virus or to develop AIDS than those of the same geographical ancestry, such as European Americans, who have fewer copies of the gene, according to a study funded by the National Institute of Allergy and Infectious Diseases (NIAID).
Today, the International Rett Syndrome Foundation announced that it will provide $200,000 in 2009 to support a newly proposed clinical trial with a growth-factor based treatment for Rett Syndrome. The study will be carried out by a team of clinical trials specialists at the Boston Children's Hospital, led by Dr. Omar Khwaja MD, PhD and will be the first potentially disease modifying therapy ever to be tested in Rett syndrome patients.
› Verified 8 days ago
Dr. Enyinnaya Rose Nwaneri, M.D.,M.P.H. Anesthesiology Medicare: Medicare Enrolled Practice Location: 1221 Mercantile Ln, Upper Marlboro, MD 20774 Phone: 301-395-2074 | |
Sasha Rochelle Jarrett, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 1221 Mercantile Ln, Upper Marlboro, MD 20774 Phone: 301-456-4368 | |
Weijia Xia Yan, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 1221 Mercantile Ln, Upper Marlboro, MD 20774 Phone: 361-855-0001 | |
Dr. Megan Campion, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: Largo Medical Center, 1221 Mercantile Ln, Upper Marlboro, MD 20774 Phone: 301-618-5500 | |
Harold T. Rowson, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 5714 Kenfield Ln, Upper Marlboro, MD 20772 Phone: 301-325-3558 | |
Dr. Jonathan Tze-wei Ho, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1221 Mercantile Ln, Upper Marlboro, MD 20774 Phone: 202-306-5341 | |
Dr. Min-shue Alvin Chen, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 1221 Mercantile Ln, Upper Marlboro, MD 20774 Phone: 301-386-6718 |